SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-030291
Filing Date
2018-11-29
Accepted
2018-11-29 16:53:13
Documents
71
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q phas-10q_20180930.htm 10-Q 2336336
2 EX-31.1 phas-ex311_46.htm EX-31.1 16771
3 EX-31.2 phas-ex312_47.htm EX-31.2 16756
4 EX-32.1 phas-ex321_49.htm EX-32.1 7591
5 EX-32.2 phas-ex322_48.htm EX-32.2 7591
  Complete submission text file 0001564590-18-030291.txt   8090565

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT phas-20180930.xml EX-101.INS 1725270
7 XBRL TAXONOMY EXTENSION SCHEMA phas-20180930.xsd EX-101.SCH 55530
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phas-20180930_cal.xml EX-101.CAL 40767
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phas-20180930_def.xml EX-101.DEF 228299
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE phas-20180930_lab.xml EX-101.LAB 422822
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phas-20180930_pre.xml EX-101.PRE 365023
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 181209001
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1